A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

NCT02570126 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1236

Enrollment

INDUSTRY

Sponsor class

Conditions

Chicken-pox Illness (Varicella Virus Disease)
Chickenpox

Interventions

BIOLOGICAL: Varilrix HSA-free
BIOLOGICAL: Varilrix™

Sponsor

GlaxoSmithKline